Evaluation of 99mTc-UBI 29-41 scintigraphy for specific detection of experimental Staphylococcus aureus prosthetic joint infections

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 8, 2007, Pages 1302-1309

  Sarda Mantel, Laure ^a,b,c   Saleh Mghir, Azzam ^f   Welling, Mick M ^d   Meulemans, Alain ^a,b,c   Vrigneaud, Jean Marc ^a,b,c   Raguin, Olivier ^a,b,c   Hervatin, Florence ^a,e   Martet, Geneviève ^a,c   Chau, Françoise ^a   Lebtahi, Rachida ^a,b,c   Le Guludec, Dominique ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BICHAT HOSPITAL   (France)

^c INSERM   (France)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e DIF   (France)

^f LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Antimicrobial peptide; Prosthetic joint infection; Rabbits; Scintigraphy; Technetium

Indexed keywords

RADIOPHARMACEUTICAL AGENT; SODIUM CHLORIDE; UBIQUICIDIN 29 41 TC 99M; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; DIAGNOSTIC AGENT; PEPTIDE FRAGMENT; TECHNETIUM 99M UBIQUICIDIN(29 41); TECHNETIUM 99M UBIQUICIDIN(29-41); TECHNETIUM COMPLEX; TRACER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCULATION; EVALUATION; EXPERIMENTAL INFECTION; FEMALE; INFECTIOUS ARTHRITIS; INJECTION; JOINT PROSTHESIS; JOINT SCINTISCANNING; KINETICS; KNEE; KNEE ARTHRITIS; KNEE ARTHROPLASTY; MOUSE; NEW ZEALAND; NONHUMAN; RABBIT; SCINTILLATION CAMERA; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; VALIDATION STUDY; ANIMAL; CHEMISTRY; JOINT; LIMB; METABOLISM; METHODOLOGY; MICROBIOLOGY; PROSTHESIS FAILURE; SCINTISCANNING; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; EXTREMITIES; FEMALE; GAMMA CAMERAS; JOINTS; ORGANOTECHNETIUM COMPOUNDS; PEPTIDE FRAGMENTS; PROSTHESIS FAILURE; RABBITS; RADIOACTIVE TRACERS; RADIONUCLIDE IMAGING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 34548081725     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0368-7     Document Type: Article

References (40)

1. Lentino JR. Infections associated with prosthetic knee and prosthetic hip. Curr Infect Dis Rep 2004;6:388-92.
2. Lidgren L, Knutson K, Stefansdottir A. Infection and arthritis. Infection of prosthetic joints. Best Pract Res Clin Rheumatol 2003;17:209-18.
3. Bernard L, Hoffmeyer P, Assal M, Vaudaux P, Schrenzel J, Lew D. Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother 2004;53:127-9.
4. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004;351:1645-54.
5. Anguita-Alonso P, Hanssen AD, Patel R. Prosthetic joint infection. Expert Rev Anti Infect Ther 2005;3:797-804.
6. Osmon DR, Hanssen AD, Patel R. Prosthetic joint infection: criteria for future definitions. Clin Orthop Relat Res 2005:89-90.
7. Bernard L, Lubbeke A, Stern R, Bru JP, Feron JM, Peyramond D, et al. Value of preoperative investigations in diagnosing prosthetic joint infection: retrospective cohort study and literature review. Scand J Infect Dis 2004;36:410-6.
8. Frank KL, Hanssen AD, Patel R. icaA is not a useful diagnostic marker for prosthetic joint infection. J Clin Microbiol 2004;42:4846-9.
9. Gupta MN, Sturrock RD, Field M. Prospective comparative study of patients with culture proven and high suspicion of adult onset septic arthritis. Ann Rheum Dis 2003;62:327-31.
10. Patel R, Osmon DR, Hanssen AD. The diagnosis of prosthetic joint infection: current techniques and emerging technologies. Clin Orthop Relat Res 2005:55-8.
11. Palestro CJ. Nuclear medicine, the painful prosthetic joint, and orthopedic infection. J Nucl Med 2003;44:927-9.
12. 99mTc-sulfur colloid marrow imaging. J Nucl Med 2004;45:1864-71.
13. 18FDG-PET for the detection of infected hip prosthesis. Eur J Nucl Med Mol Imaging 2003;30:705-15.
14. Joseph TN, Mujtaba M, Chen AL, Maurer SL, Zuckerman JD, Maldjian C, et al. Efficacy of combined technetium-99m sulfur colloid/indium-111 leukocyte scans to detect infected total hip and knee arthroplasties. J Arthroplasty 2001;16:753-8.
15. 99mTc infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet 1996;347:233-5.
16. Yapar Z, Kibar M, Yapar AF, Togrul E, Kayaselcuk U, Sarpel Y. The efficacy of technetium-99m ciprofloxacin (Infecton) imaging in suspected orthopaedic infection: a comparison with sequential bone/gallium imaging. Eur J Nucl Med 2001;28:822-30.
17. 99mTc white blood cell and three-phase bone imaging in the diagnosis of hip prosthesis infections: improved diagnostic accuracy with extended imaging time. Nucl Med Commun 2002;23:655-61.
18. Dumarey N, Blocklet D, Appelboom T, Tant L, Schoutens A. Infecton is not specific for bacterial osteo-articular infective pathology. Eur J Nucl Med Mol Imaging 2002;29:530-5.
19. 99mTc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus aureus prosthetic joint infection. J Nucl Med 2002;43:239-45.
20. 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med 2003;44:920-6.
21. Appelboom T, Emery P, Tant L, Dumarey N, Schoutens A. Evaluation of technetium-99m-ciprofloxacin (Infecton) for detecting sites of inflammation in arthritis. Rheumatology (Oxford) 2003;42:1179-82.
22. Lupetti A, Welling MM, Pauwels EK, Nibbering PH. Radiolabelled antimicrobial peptides for infection detection. Lancet Infect Dis 2003;3:223-9.
23. 99mTc-UBI specificity for bacteria. Nucl Med Biol 2003;30:597-603.
24. Welling MM, Paulusma-Annema A, Balter HS, Pauwels EK, Nibbering PH. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med 2000;27:292-301.
25. 99mTc-UBI 29-41 in humans. Nucl Med Biol 2004;31:373-9.
26. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med 2001;42:788-94.
27. 99mTc-UBI 29-41 for imaging of bacterial infections. Nucl Med Biol 2002;29:413-22.
28. 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41. Nucl Med Biol 2004;31:503-9.
29. Belmatoug N, Cremieux AC, Bleton R, Volk A, Saleh-Mghir A, Grossin M, et al. A new model of experimental prosthetic joint infection due to methicillin-resistant Staphylococcus aureus: a microbiologic, histopathologic, and magnetic resonance imaging characterization. J Infect Dis 1996;174:414-7.
30. 14C]sparfloxacin in experimental Staphylococcus aureus joint prosthesis infection. Antimicrob Agents Chemother 1996;40:2111-6.
31. Chun L, Yoon J, Song Y, Huie P, Regula D, Goodman S. The characterization of macrophages and osteoclasts in tissues harvested from revised total hip prostheses. J Biomed Mater Res 1999;48:899-903.
32. 99mTc- antimicrobial peptides: promising candidates for infection imaging. Q J Nucl Med 2003;47:238-45.
33. Park Y, Hahm KS. Antimicrobial peptides (AMPs): peptide structure and mode of action. J Biochem Mol Biol 2005;38:507-16.
34. 99mTc-UBI 29-41 based on experimental and semiempirical results. Appl Radiat Isot 2004;61:1261-8.
35. 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial. J Nucl Med 2005;46:567-73.
36. 99mTc-labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J Nucl Med 2004;45:321-6.
37. Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastian JF, et al. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med 2005;202:209-15.
38. Widmer AF. New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis 2001;33(Suppl 2):S94-106.
39. Warnke PH, Springer IN, Russo PA, Wiltfang J, Essig H, Kosmahl M, et al. Innate immunity in human bone. Bone 2006;38:400-8.
40. 99mTc-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphylococcus aureus infection. J Nucl Med 2004;45:849-56.